MedPath

SOM-PAM

SOM-PAM

Dormant
DIN Number

00414220

Drug Class

Human

Market Date

Dec 31, 1981

Company
HC

biomed pharma

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00414220
AIG Number0108704002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Targeted (CDSA IV)
A
ATC Code
N05CD01 FLURAZEPAM
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:24.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

FLURAZEPAM HYDROCHLORIDEActive
Strength: 15 MG
Monograph: FLURAZEPAM HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.